Clinical Toxicology 2010-06-01

Etofenamate associated with Lyell syndrome: a case report.

Yalcin Golcuk, Deniz Oray, Ozge Duman Atilla, Nilay Tefennioglu

Index: Clin. Toxicol. (Phila.) 48(5) , 471-2, (2010)

Full Text: HTML

Abstract

Toxic epidermal necrolysis (Lyell syndrome) is a rare, acute, and potentially life-threatening mucocutaneous disease that is most often triggered by drugs. This is the first case of toxic epidermal necrolysis because of treatment with etofenamate of which we are aware.

Related Compounds

  • Etofenamate

Related Articles:

Adverse reaction of topical etofenamate: petechial eruption.

2012-10-01

[West Indian Med. J. 61(7) , 767-9, (2012)]

Turpentine sensitization in a nonsteroidal anti-inflammatory solution user.

2012-01-01

[Dermatitis 23(4) , 182-3, (2012)]

Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant.

2012-06-01

[Environ. Sci. Pollut. Res. Int. 19(5) , 1818-27, (2012)]

[Plasma- and tissue concentrations following intramuscular administration of etofenamat. Pharmacokinetics of etofenamat and flufenamic acid in plasma, synovium, and tissues of patients with chronic polyarthritis after administration of an oily solution of etofenamat].

1992-12-01

[Arzneimittelforschung 42(12) , 1487-91, (1992)]

Effects of some pharmacological agents on the survival of unipedicled venous flaps: an experimental study.

2001-01-01

[Microsurgery 21(8) , 350-6, (2001)]

More Articles...